thiophenes has been researched along with Osteoporotic Fractures in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (2.04) | 29.6817 |
| 2010's | 46 (93.88) | 24.3611 |
| 2020's | 2 (4.08) | 2.80 |
| Authors | Studies |
|---|---|
| Elgebaly, Z; Elliott, J; Naik-Panvelkar, P; Norman, S; Pollack, A; Seibel, MJ; Thistlethwaite, J; Weston, C | 1 |
| Fan, X; Wang, D; Yan, C; Zhou, L | 1 |
| Feola, M; Liuni, FM; Pistillo, P; Saturnino, L; Scialdoni, A; Tarantino, U; Tempesta, V | 1 |
| Capone, A; Marongiu, G; Mastio, M | 1 |
| Hamilton, JL; Ross, RD; Sumner, DR; Virdi, AS; Wilson, BM | 1 |
| Geusens, P; Lems, WF | 1 |
| Beaudart, Ch; Bruyere, O; Buckinx, F; Disteche, S; Neuprez, A; Reginster, JY; Slomian, J | 1 |
| Gosch, M; Kammerlander, C; Nicholas, JA | 1 |
| Gambacciani, M; Levancini, M | 1 |
| Bouvet, A; Caruba, T; Pouchot, J; Sabatier, B; Savoldelli, V | 1 |
| Bolland, MJ; Grey, A | 1 |
| Reid, IR | 1 |
| Dullin, C; Ebert, J; Komrakova, M; Sehmisch, S; Stuermer, KM; Tezval, M; Weidemann, A | 1 |
| Casella, F; Fabbri, L; Guido, G; Scaglione, M | 1 |
| Andreopoulou, P; Hegde, V; Jo, JE; Lane, JM | 1 |
| Matikainen, N | 1 |
| de Villiers, TJ | 1 |
| Badurski, J; Collette, J; Compston, J; Cormier, C; Diaz-Curiel, M; Isaia, G; Marquis, P; Meunier, PJ; Ortolani, S; Reginster, JY; Roux, C; Wark, JD | 1 |
| Bruyère, O; Hiligsmann, M; Reginster, JY | 1 |
| Boonen, S; Bruyère, O; Collette, J; Diaz-Curiel, M; Felsenberg, D; Kaufman, JM; Lorenc, R; Reginster, JY; Spector, TD | 1 |
| Borgström, F; Coelho, J; Johansson, H; Kanis, JA; McCloskey, E; Oden, A; Ström, O | 1 |
| Bruyère, O; Collette, J; Cormier, C; Decock, C; Detilleux, J; Ortolani, S; Reginster, JY; Rizzoli, R | 1 |
| Feng, G; Hu, J; Li, JH; Li, YF; Luo, E; Zhu, SS | 1 |
| Rabenda, V; Reginster, JY | 1 |
| Chappard, D; de Vernejoul, MC; Geoffroy, V; Lalande, A; Libouban, H; Marty, C; Ostertag, A | 1 |
| Boonen, S | 1 |
| Ringe, JD | 1 |
| Bergmann, P; Body, JJ; Boonen, S; Boutsen, Y; Devogelaer, JP; Goemaere, S; Kaufman, JM; Reginster, JY; Rozenberg, S | 1 |
| Charle-Crespo, MÁ; Gomes-Carvalho, CS; Guerra-García, MM; Prejigueiro-Santás, A; Puga-Sarmiento, E; Rodríguez-Fernández, JB | 1 |
| Cakıcı, H; Demir, B; Haberal, A; Ozturan, KE; Yilmaz, F; Yucel, I | 1 |
| Brandi, ML; Felsenberg, D; Marie, PJ | 1 |
| Eisman, JA; Jönsson, B; Kanis, JA; Papaioannou, A; Siris, ES; Ström, O; Tosteson, A | 1 |
| Aye, M; Doherty, SM; Middleton, ET; Steel, SA | 1 |
| Johansson, H; Kanis, JA; McCloskey, EV; Oden, A | 1 |
| Boyer, KM; Esses, SI; Finkelstein, J; Goldberg, MJ; Hitchcock, K; Jenkins, J; Keith, M; McGuire, R; Sluka, P; Turkelson, CM; Watters, WC; Wies, JL; Woodard, E | 1 |
| Bischoff-Ferrari, HA; Buck, G; Perger, L | 1 |
| Lakatos, P | 1 |
| Lecart, MP; Reginster, JY | 1 |
| Briot, K | 1 |
| Badurski, J; Balogh, A; Benhamou, CL; Brandi, ML; Bruyère, O; Devogelaer, JP; Diaz-Curiel, M; Felsenberg, D; Goemaere, S; Kaufman, JM; Reginster, JY; Roux, C; Wark, J | 1 |
| Przedlacki, J | 1 |
| Christiansen, C; Silverman, S | 1 |
| Eriksen, EF; Halse, J; Moen, MH | 1 |
| Fazzalari, NL; Larsson, S | 1 |
| Jönsson, B; Kanis, JA; Ström, O | 1 |
| Ben Sedrine, W; Bruyère, O; Hiligsmann, M; Reginster, JY | 1 |
22 review(s) available for thiophenes and Osteoporotic Fractures
| Article | Year |
|---|---|
Current options to surgical treatment in osteoporotic fractures.
Topics: Aged; Arthroplasty; Biomechanical Phenomena; Bone Nails; Femoral Fractures; Forearm Injuries; Fracture Fixation; Fracture Fixation, Internal; Fracture Healing; Humans; Humeral Fractures; Orthopedics; Osteoporotic Fractures; Quality of Life; Teriparatide; Thiophenes; Treatment Outcome | 2013 |
Pharmacologic augmentation of implant fixation in osteopenic bone.
Topics: Animals; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Combined Modality Therapy; Diphosphonates; Fracture Fixation; Fractures, Bone; Humans; Orthopedic Fixation Devices; Osseointegration; Osteoporosis; Osteoporotic Fractures; Parathyroid Hormone; Prostheses and Implants; Thiophenes | 2014 |
Established and forthcoming drugs for the treatment of osteoporosis.
Topics: Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcium; Cathepsin K; Denosumab; Diphosphonates; Humans; Osteoporosis; Osteoporotic Fractures; Parathyroid Hormone; Thiophenes; Vitamin D | 2014 |
Treatment of osteoporosis in older adults.
Topics: Aged; Aging; Antibodies, Monoclonal, Humanized; Bone Density; Denosumab; Diphosphonates; Female; Frail Elderly; Hormone Replacement Therapy; Humans; Kidney Diseases; Male; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Postmenopause; Teriparatide; Thiophenes | 2014 |
A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication record.
Topics: Bone Density Conservation Agents; Drug and Narcotic Control; Humans; Myocardial Infarction; Osteoporosis; Osteoporotic Fractures; Periodicals as Topic; Pulmonary Embolism; Research Report; Risk Assessment; Thiophenes; Venous Thromboembolism | 2014 |
Effect of osteoporosis medications on fracture healing.
Topics: Anabolic Agents; Animals; Bone Density Conservation Agents; Calcitonin; Denosumab; Diphosphonates; Disease Models, Animal; Evidence-Based Medicine; Fracture Healing; Humans; Osteoporosis; Osteoporotic Fractures; Thiophenes | 2016 |
[Osteoporosis: a clinical perspective].
Topics: Absorptiometry, Photon; Accidental Falls; Alcohol Drinking; Algorithms; Bone Density Conservation Agents; Calcium, Dietary; Diphosphonates; Exercise; Gonadal Steroid Hormones; Humans; Osteoporosis; Osteoporotic Fractures; Risk Assessment; Risk Factors; Smoking Cessation; Thiophenes; Vitamin D | 2016 |
The quest for new drugs to prevent osteoporosis-related fractures.
Topics: Benzoates; Biphenyl Compounds; Bone Density Conservation Agents; Drug Discovery; Humans; Osteoporosis; Osteoporotic Fractures; Piperidines; Propanolamines; Pyrrolidines; Tetrahydronaphthalenes; Thiophenes | 2017 |
Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover.
Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Double-Blind Method; Female; Femur Neck; Humans; Lumbar Vertebrae; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Randomized Controlled Trials as Topic; Spinal Fractures; Thiophenes; Treatment Outcome | 2010 |
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Female; Femur Neck; Follow-Up Studies; Humans; Lumbar Vertebrae; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Peptide Fragments; Procollagen; Randomized Controlled Trials as Topic; Spinal Fractures; Thiophenes | 2010 |
Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures.
Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Epidemiologic Methods; Female; Humans; Medication Adherence; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Thiophenes; Treatment Outcome | 2010 |
Addressing the age-related needs of osteoporotic patients with strontium ranelate.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Bone Density Conservation Agents; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Thiophenes; Treatment Outcome | 2010 |
Strontium ranelate: an effective solution for diverse fracture risks.
Topics: Body Mass Index; Bone Density Conservation Agents; Female; Genetic Predisposition to Disease; Glucocorticoids; Humans; Male; Organometallic Compounds; Osteoporosis; Osteoporotic Fractures; Risk Factors; Smoking; Thiophenes | 2010 |
Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Thiophenes | 2010 |
How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis.
Topics: Aged; Animals; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Thiophenes | 2011 |
A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(®).
Topics: Aged; Aged, 80 and over; Algorithms; Bone Density Conservation Agents; Clinical Trials, Phase III as Topic; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Randomized Controlled Trials as Topic; Risk Factors; Spinal Fractures; Thiophenes | 2011 |
[Pharmacologic treatment of osteoporosis--2011].
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density; Bone Density Conservation Agents; Calcium; Cost-Benefit Analysis; Denosumab; Diphosphonates; Drug Costs; Drug Therapy, Combination; Estrogen Replacement Therapy; Humans; Hungary; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; RANK Ligand; Teriparatide; Thiophenes; Vitamin D | 2011 |
Current options for the management of postmenopausal osteoporosis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcium; Denosumab; Dietary Supplements; Diphosphonates; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Parathyroid Hormone; RANK Ligand; Selective Estrogen Receptor Modulators; Thiophenes; Vitamin D | 2011 |
[Strontium ranelate in post-menopausal osteoporosis].
Topics: Bone Density; Bone Density Conservation Agents; Bone Resorption; Female; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Postmenopause; Randomized Controlled Trials as Topic; Thiophenes | 2011 |
Individualizing osteoporosis therapy.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcitonin; Denosumab; Diphosphonates; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Precision Medicine; Teriparatide; Thiophenes | 2012 |
New developments in the treatment of osteoporosis.
Topics: Algorithms; Anorexia; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Resorption; Calcitonin; Calcium, Dietary; Decision Making; Denosumab; Diphosphonates; Estrogen Replacement Therapy; Female; Humans; Hyperparathyroidism, Secondary; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Practice Guidelines as Topic; RANK Ligand; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Vitamin D; Vitamin D Deficiency | 2013 |
Anti-osteoporosis therapy and fracture healing.
Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Proteins; Bone Remodeling; Bony Callus; Diphosphonates; Fracture Healing; Humans; Organometallic Compounds; Osteoporotic Fractures; Parathyroid Hormone; RANK Ligand; Thiophenes; Wound Healing | 2014 |
5 trial(s) available for thiophenes and Osteoporotic Fractures
| Article | Year |
|---|---|
Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bony Callus; Casts, Surgical; Chemotherapy, Adjuvant; Female; Fracture Fixation; Fracture Healing; Humans; Male; Middle Aged; Osteoporotic Fractures; Radiography; Thiophenes; Treatment Outcome; Ultrasonography; Wrist Injuries | 2016 |
Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.
Topics: Absorptiometry, Photon; Aged; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Drug Administration Schedule; Female; Femur Neck; Humans; Lumbar Vertebrae; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Quality of Life; Spinal Fractures; Thiophenes; Treatment Outcome | 2009 |
Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women.
Topics: Aged; Aged, 80 and over; Belgium; Bone Density; Bone Density Conservation Agents; Cost-Benefit Analysis; Drug Administration Schedule; Epidemiologic Methods; Female; Health Care Costs; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Quality-Adjusted Life Years; Thiophenes | 2010 |
The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years.
Topics: Aged; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Follow-Up Studies; Hip Joint; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Retreatment; Spine; Thiophenes; Treatment Outcome | 2012 |
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis.
Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Drug Administration Schedule; Female; Femur Neck; Follow-Up Studies; Hip Joint; Humans; Lumbar Vertebrae; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Thiophenes; Time Factors; Treatment Outcome | 2012 |
22 other study(ies) available for thiophenes and Osteoporotic Fractures
| Article | Year |
|---|---|
Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice.
Topics: Aged; Aged, 80 and over; Attitude of Health Personnel; Australia; Bone Density Conservation Agents; Denosumab; Deprescriptions; Diphosphonates; Drug Substitution; Female; General Practice; General Practitioners; Humans; Longitudinal Studies; Male; Middle Aged; Norpregnenes; Osteoporosis; Osteoporotic Fractures; Practice Patterns, Physicians'; Raloxifene Hydrochloride; Retrospective Studies; Teriparatide; Thiophenes | 2020 |
Changes in BMP-2 expression and mechanical properties during treatment of rats with osteoporotic hindlimb fracture with strontium ranelate.
Topics: Animals; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Female; Fracture Healing; Gene Expression; Hindlimb; Osteoporotic Fractures; Rats; Rats, Sprague-Dawley; Thiophenes; Treatment Outcome | 2020 |
Fracture healing in elderly patients: new challenges for antiosteoporotic drugs.
Topics: Aged; Bone and Bones; Bone Density Conservation Agents; Female; Fracture Fixation, Internal; Fracture Healing; Frail Elderly; Humans; Humeral Fractures; Osteoporosis; Osteoporotic Fractures; Radiography; Thiophenes | 2013 |
Bone forming agents for the management of osteoporosis.
Topics: Adaptor Proteins, Signal Transducing; Aged; Animals; Antibodies, Monoclonal; Bone Density Conservation Agents; Bone Morphogenetic Proteins; Bone Resorption; Europe; Female; Genetic Markers; Humans; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Parathyroid Hormone; Teriparatide; Thiophenes | 2014 |
[Strontium ranelate. Long-term control of fractures over 10 years].
Topics: Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Long-Term Care; Osteoporotic Fractures; Spinal Fractures; Thiophenes | 2014 |
Management of postmenopausal osteoporosis and the prevention of fractures.
Topics: Anabolic Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density; Bone Density Conservation Agents; Denosumab; Diphosphonates; Female; Hormone Replacement Therapy; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Phytoestrogens; Radiography; Risk Factors; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Treatment Outcome | 2014 |
Evaluation of the prescription of osteoporosis treatment after a major osteoporotic fracture.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Dietary Supplements; Diphosphonates; Female; Follow-Up Studies; Fractures, Bone; France; Hip Fractures; Humans; Imidazoles; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Prescriptions; Raloxifene Hydrochloride; Retrospective Studies; Thiophenes; Treatment Outcome; Vitamin D; Wrist Injuries; Zoledronic Acid | 2014 |
Efficacy, effectiveness and side effects of medications used to prevent fractures.
Topics: Alendronate; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcium Compounds; Denosumab; Diphosphonates; Etidronic Acid; Evidence-Based Medicine; Hip Fractures; Humans; Ibandronic Acid; Imidazoles; Osteoporosis; Osteoporotic Fractures; Raloxifene Hydrochloride; Risedronic Acid; Risk Assessment; Spinal Fractures; Teriparatide; Thiophenes; Treatment Outcome; Vitamin D; Zoledronic Acid | 2015 |
The Impact of Strontium Ranelate on Metaphyseal Bone Healing in Ovariectomized Rats.
Topics: Animals; Bone Density Conservation Agents; Disease Models, Animal; Female; Fracture Healing; Humans; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Osteotomy; Ovariectomy; Rats; Rats, Sprague-Dawley; Thiophenes; X-Ray Microtomography | 2015 |
[Preventing fractures with strontium ranelate].
Topics: Aged; Bone Density; Bone Density Conservation Agents; Female; Humans; Male; Middle Aged; Osteoporotic Fractures; Spinal Fractures; Thiophenes | 2015 |
The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis.
Topics: Age Factors; Aged; Aged, 80 and over; Algorithms; Bone Density Conservation Agents; Cost-Benefit Analysis; Drug Costs; Epidemiologic Methods; Female; Health Care Costs; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Quality of Life; Quality-Adjusted Life Years; Thiophenes; United Kingdom | 2010 |
Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats.
Topics: Absorptiometry, Photon; Animals; Biomechanical Phenomena; Bone Density Conservation Agents; Combined Modality Therapy; Drug Evaluation, Preclinical; Female; Fracture Fixation; Fracture Healing; Organometallic Compounds; Osteoporotic Fractures; Ovariectomy; Rats; Rats, Sprague-Dawley; Thiophenes; Tibia; Tibial Fractures; X-Ray Microtomography | 2010 |
Strontium ranelate decreases the incidence of new caudal vertebral fractures in a growing mouse model with spontaneous fractures by improving bone microarchitecture.
Topics: Animals; Bone Density Conservation Agents; Calcium; Cauda Equina; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Fractures, Spontaneous; Lumbar Vertebrae; Mice; Mice, Transgenic; Organometallic Compounds; Osteoporosis; Osteoporotic Fractures; Spinal Fractures; Stress, Mechanical; Strontium; Thiophenes; Tibia | 2011 |
[Incidence of hip fractures due to osteoporosis in relation to the prescription of drugs for their prevention and treatment in Galicia, Spain].
Topics: Aged; Alendronate; Bone Density Conservation Agents; Drug Prescriptions; Etidronic Acid; Female; Hip Fractures; Humans; Incidence; Male; Middle Aged; Organometallic Compounds; Osteoporotic Fractures; Retrospective Studies; Risedronic Acid; Spain; Thiophenes | 2011 |
Effect of strontium ranelate on fracture healing in the osteoporotic rats.
Topics: Animals; Biomechanical Phenomena; Bone Density; Bone Density Conservation Agents; Disease Models, Animal; Female; Fracture Healing; Organometallic Compounds; Osteoporotic Fractures; Rats; Rats, Sprague-Dawley; Thiophenes | 2011 |
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis.
Topics: Aged; Aged, 80 and over; Alendronate; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Cohort Studies; Cost-Benefit Analysis; Denosumab; Etidronic Acid; Female; Humans; Markov Chains; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Patient Compliance; Quality-Adjusted Life Years; RANK Ligand; Risedronic Acid; Thiophenes | 2011 |
The treatment of symptomatic osteoporotic spinal compression fractures.
Topics: Bone Density Conservation Agents; Calcitonin; Combined Modality Therapy; Diphosphonates; Evidence-Based Medicine; Fractures, Compression; Humans; Ibandronic Acid; Nerve Block; Organometallic Compounds; Osteoporotic Fractures; Pain Measurement; Spinal Fractures; Thiophenes; Vertebroplasty | 2011 |
[Osteoporosis].
Topics: Absorptiometry, Photon; Aged; Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcitonin; Calcium; Denosumab; Diphosphonates; Female; Femoral Neck Fractures; Humans; Male; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; RANK Ligand; Risk Factors; Selective Estrogen Receptor Modulators; Spinal Diseases; Teriparatide; Thiophenes; Vitamin D | 2011 |
Sequential osteoporosis treatments.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Comorbidity; Drug Therapy, Combination; Female; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Patient Compliance; Risk Factors; Severity of Illness Index; Thiophenes | 2011 |
Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis.
Topics: Aged; Aged, 80 and over; Alendronate; Algorithms; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Cost-Benefit Analysis; Denosumab; Drug Costs; Etidronic Acid; Female; Health Care Costs; Humans; Middle Aged; Models, Econometric; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Quality of Life; RANK Ligand; Risedronic Acid; Risk Assessment; Thiophenes; United Kingdom | 2013 |
[Osteoporosis in the man: broad indication for strontium ranelate].
Topics: Aged; Bone Density; Bone Density Conservation Agents; Evidence-Based Medicine; Guideline Adherence; Humans; Male; Organometallic Compounds; Osteoporosis; Osteoporotic Fractures; Randomized Controlled Trials as Topic; Thiophenes | 2012 |
Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.
Topics: Aged; Belgium; Bone Density; Bone Density Conservation Agents; Cost-Benefit Analysis; Drug Costs; Female; Femur Neck; Health Care Costs; Humans; Incidence; Lumbar Vertebrae; Male; Models, Econometric; Osteoporosis; Osteoporotic Fractures; Quality-Adjusted Life Years; Thiophenes | 2013 |